Ardsley Advisory Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$24.9M |
| 2 |
Shoals Technologies Group
SHLS
|
+$18.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$16.7M |
| 4 |
Modine Manufacturing
MOD
|
+$16.5M |
| 5 |
Boston Scientific
BSX
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$40.5M |
| 2 |
Eli Lilly
LLY
|
+$35.5M |
| 3 |
First Solar
FSLR
|
+$30.7M |
| 4 |
argenx
ARGX
|
+$20.2M |
| 5 |
Advanced Energy
AEIS
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.08% |
| 2 | Healthcare | 13.31% |
| 3 | Consumer Discretionary | 7.84% |
| 4 | Financials | 6.74% |
| 5 | Communication Services | 6.07% |
Similar funds
Ardsley Advisory Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Ardsley Advisory Partners held 214 positions worth $784M, down 14% from $911M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ardsley Advisory Partners withdrew a net $154M in Q1 2026, closing 63 positions and reducing 34 holdings. Its most notable exit was First Solar, an estimated $30.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ardsley Advisory Partners opened a new position in United Therapeutics worth $29.6M.
- Ardsley Advisory Partners's largest Q1 2026 buy was United Therapeutics: 50,000 shares worth $29.6M.
- Ardsley Advisory Partners added most to Shoals Technologies Group in Q1 2026, an estimated $18.3M increase.
- Ardsley Advisory Partners's biggest Q1 2026 reduction was Lumentum, cutting an estimated $40.5M.
- Ardsley Advisory Partners fully exited First Solar in Q1 2026, selling an estimated $30.7M.
- Ardsley Advisory Partners's ten largest holdings make up 30% of its $784M portfolio in Q1 2026.
- Ardsley Advisory Partners opened 72 new positions and closed 63 in Q1 2026.
- Ardsley Advisory Partners's portfolio value fell 14% quarter-over-quarter to $784M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2026, filed 15 May 2026.